Recombinant multi-species MAP2K3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MAP2K3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is activated by mitogenic and environmental stress, and participates in the MAP kinase-mediated signaling cascade. It phosphorylates and thus activates MAPK14/p38-MAPK. This kinase can be activated by insulin, and is necessary for the expression of glucose transporter. Expression of RAS oncogene is found to result in the accumulation of the active form of this kinase, which thus leads to the constitutive activation of MAPK14, and confers oncogenic transformation of primary cells. The inhibition of this kinase is involved in the pathogenesis of Yersina pseudotuberculosis. Multiple alternatively spliced transcript variants that encode distinct isoforms have been reported for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: Dual specificity mitogen-activated protein kinase kinase 3,MAP kinase kinase 3,MAP2K3,MAPK/ERK kinase 3 (MEK 3),MAPKK 3,MAPKK3,MEK3,MKK3,MKK3b,Map2k3,Mek3,Mkk3,PRKMK3,Prkmk3,SAPKK-2,SAPKK2,SAPKK2),Stress-activated protein kinase kinase 2 (SAPK kinase 2
Go
to MAP2K3 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP10374-Ag-1/ GM-Tg-hg-IP10374-Ag-2 | Human MAP2K3 protein | Human |
| GM-Tg-rg-IP10374-Ag-1/ GM-Tg-rg-IP10374-Ag-2 | Rat MAP2K3 protein | Rat |
| GM-Tg-mg-IP10374-Ag-1/ GM-Tg-mg-IP10374-Ag-2 | Mouse MAP2K3 protein | Mouse |
| GM-Tg-cynog-IP10374-Ag-1/ GM-Tg-cynog-IP10374-Ag-2 | Cynomolgus/Rhesus macaque MAP2K3 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP10374-Ag-1/ GM-Tg-felg-IP10374-Ag-2 | Feline MAP2K3 protein | Feline |
| GM-Tg-cang-IP10374-Ag-1/ GM-Tg-cang-IP10374-Ag-2 | Canine MAP2K3 protein | Canine |
| GM-Tg-bovg-IP10374-Ag-1/ GM-Tg-bovg-IP10374-Ag-2 | Bovine MAP2K3 protein | Bovine |
| GM-Tg-equg-IP10374-Ag-1/ GM-Tg-equg-IP10374-Ag-2 | Equine MAP2K3 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP10374-Ag-1/ GM-Tg-hg-IP10374-Ag-2;
GM-Tg-rg-IP10374-Ag-1/ GM-Tg-rg-IP10374-Ag-2;
GM-Tg-mg-IP10374-Ag-1/ GM-Tg-mg-IP10374-Ag-2; GM-Tg-cynog-IP10374-Ag-1/ GM-Tg-cynog-IP10374-Ag-2; GM-Tg-felg-IP10374-Ag-1/ GM-Tg-felg-IP10374-Ag-2; GM-Tg-cang-IP10374-Ag-1/ GM-Tg-cang-IP10374-Ag-2; GM-Tg-bovg-IP10374-Ag-1/ GM-Tg-bovg-IP10374-Ag-2; GM-Tg-equg-IP10374-Ag-1/ GM-Tg-equg-IP10374-Ag-2 |
| Products Name | MAP2K3 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | MAP2K3 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MAP2K3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.